This company listing is no longer active
Atreca Croissance future
Future contrôle des critères 0/6
Atreca is forecast to grow earnings at 4.3% per annum.
Informations clés
4.3%
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Biotechs croissance des bénéfices | 35.6% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 31 May 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | N/A | -52 | N/A | N/A | 1 |
12/31/2025 | N/A | -48 | N/A | N/A | 1 |
12/31/2024 | N/A | -38 | N/A | N/A | 1 |
12/31/2023 | N/A | -65 | N/A | N/A | 1 |
9/30/2023 | N/A | -98 | -65 | -65 | N/A |
6/30/2023 | N/A | -85 | -65 | -64 | N/A |
3/31/2023 | N/A | -93 | -71 | -70 | N/A |
12/31/2022 | N/A | -97 | -82 | -81 | N/A |
9/30/2022 | N/A | -105 | -86 | -81 | N/A |
6/30/2022 | N/A | -110 | -88 | -81 | N/A |
3/31/2022 | N/A | -108 | -93 | -69 | N/A |
12/31/2021 | N/A | -109 | -96 | -61 | N/A |
9/30/2021 | N/A | -103 | -96 | -63 | N/A |
6/30/2021 | N/A | -98 | -93 | -62 | N/A |
3/31/2021 | N/A | -92 | -82 | -66 | N/A |
12/31/2020 | N/A | -86 | -72 | -67 | N/A |
9/30/2020 | N/A | -83 | -70 | -65 | N/A |
6/30/2020 | N/A | -76 | -71 | -65 | N/A |
3/31/2020 | N/A | -74 | -67 | -63 | N/A |
12/31/2019 | N/A | -67 | -62 | -59 | N/A |
9/30/2019 | N/A | -59 | -56 | -53 | N/A |
6/30/2019 | N/A | -53 | -47 | -45 | N/A |
3/31/2019 | N/A | -44 | -41 | -40 | N/A |
12/31/2018 | N/A | -38 | -36 | -35 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 0C1 is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: 0C1 is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: 0C1 is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if 0C1's revenue is forecast to grow faster than the German market.
Croissance élevée des revenus: 0C1 is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if 0C1's Return on Equity is forecast to be high in 3 years time